Skip to main content
. 2022 Nov 3;19(21):14424. doi: 10.3390/ijerph192114424

Figure 3.

Figure 3

Impurity concentrations (expressed as percent difference relative to FDA specifications). Duplicate samples noted with † (expressed as percent difference relative to FDA specifications). Cells denoted with asterisks (*) refer to instances when impurity concentrations were equivalent to one half LOQ.